Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Weiss

Showing results (131-140 of 177) with videos related to

Pageof 18
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 12, 2024
Dimethylene-Cyclopropanide Units as Building Blocks for Fluorescence DyesMargarita Yanbaeva, Jan Soyka, Jana M Holthoff, et al.
The Journal of Clinical Endocrinology and Metabolism|June 2, 2015
Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized TrialHarold Bays, Daniel Gaudet, Robert Weiss, et al.
JAMA|September 11, 2003
Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trialHoward Trachtman, Avital Cnaan, Erica Christen, et al.
Plastic and Reconstructive Surgery|September 20, 2022
A Randomized Trial to Assess Effectiveness and Safety of a Hyaluronic Acid Filler for Chin Augmentation and Correction of Chin RetrusionKeith Marcus, Amir Moradi, Joely Kaufman-Janette, et al.
Heart Rhythm|April 27, 2005
Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experienceD George Wyse, April Slee, Andrew E Epstein, et al.
Urology|September 29, 2020
AUTHOR REPLYChristopher J Warren, John Wisener, Chrystal Chang, et al.
American Heart Journal|April 29, 2006
Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) IIChristie M Ballantyne, Marcelo Bertolami, Hugo Ricardo Hernandez Garcia, et al.
Urology|July 12, 2020
PubMed-Indexed Research Productivity of Students Matching at Top Urology Programs: 2017-2020Christopher J Warren, John Wisener, Chrystal Chang, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 15, 2021
A Randomized, Controlled, Evaluator-Blinded, Multi-Center Study of Hyaluronic Acid Filler Effectiveness and Safety in Lip Fullness AugmentationRobert Weiss, Kenneth Beer, Sue E Cox, et al.
International Journal of Cardiology|November 26, 2016
Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatmentRobert Dufour, Jean Bergeron, Daniel Gaudet, et al.
Pageof 18

Showing results (131-140 of 177) with videos related to

Sort By:
Pageof 18
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 12, 2024
Dimethylene-Cyclopropanide Units as Building Blocks for Fluorescence DyesMargarita Yanbaeva, Jan Soyka, Jana M Holthoff, et al.
The Journal of Clinical Endocrinology and Metabolism|June 2, 2015
Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized TrialHarold Bays, Daniel Gaudet, Robert Weiss, et al.
JAMA|September 11, 2003
Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trialHoward Trachtman, Avital Cnaan, Erica Christen, et al.
Plastic and Reconstructive Surgery|September 20, 2022
A Randomized Trial to Assess Effectiveness and Safety of a Hyaluronic Acid Filler for Chin Augmentation and Correction of Chin RetrusionKeith Marcus, Amir Moradi, Joely Kaufman-Janette, et al.
Heart Rhythm|April 27, 2005
Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experienceD George Wyse, April Slee, Andrew E Epstein, et al.
Urology|September 29, 2020
AUTHOR REPLYChristopher J Warren, John Wisener, Chrystal Chang, et al.
American Heart Journal|April 29, 2006
Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) IIChristie M Ballantyne, Marcelo Bertolami, Hugo Ricardo Hernandez Garcia, et al.
Urology|July 12, 2020
PubMed-Indexed Research Productivity of Students Matching at Top Urology Programs: 2017-2020Christopher J Warren, John Wisener, Chrystal Chang, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 15, 2021
A Randomized, Controlled, Evaluator-Blinded, Multi-Center Study of Hyaluronic Acid Filler Effectiveness and Safety in Lip Fullness AugmentationRobert Weiss, Kenneth Beer, Sue E Cox, et al.
International Journal of Cardiology|November 26, 2016
Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatmentRobert Dufour, Jean Bergeron, Daniel Gaudet, et al.
Pageof 18